Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro.

Slides:

Advertisements

Similar presentations

Frances A Shepherd, MD, Rafael Rosell, MD Journal of Thoracic Oncology

Advertisements

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Stephen R. Broderick, MD, MPHS

E-cadherin expression associated with differentiation and prognosis in patients with non–small cell lung cancer Dage Liu, MD, Cheng-long Huang, MD, Kotaro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer Shinjiro.

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Squamous cell carcinoma tumor thrombus encountered during Mohs micrographic surgery Gary Mendese, MD, Jeremy Bordeaux, MD, MPH, Sean Pattee, MD, Mary.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26

Results of Surgical Treatment for Patients with Small Cell Lung Cancer

Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung Kenzo Hiroshima, MD, Akira Iyoda, MD, Kiyoshi Shibuya, MD, Tetsuya.

Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Tumor Angiogenesis as a Prognostic Marker in Operable Non–Small Cell Lung Cancer Katsuhiko Matsuyama, Yukio Chiba, Masato Sasaki, Hirokazu Tanaka, Ryusuke.

High Expression of Zinc-Binding Protein-89 Predicts Decreased Survival in Esophageal Squamous Cell Cancer Shu-Mei Yan, MD, Hui-Ni Wu, MB, Fan He, MD,

Tumors of the esophagogastric junction

Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer Kyoji Hirai, MD, Kiyoshi Koizumi, MD, Shuji Haraguchi, MD,

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

Lobe-specific extent of systematic lymph node dissection for non–small cell lung carcinomas according to a retrospective study of metastasis and prognosis

Prognostic Impact of Fibroblast Growth Factor 2 in Non-small Cell Lung Cancer: Coexpression with VEGFR-3 and PDGF-B Predicts Poor Survival Tom Donnem,

Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD

Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non- small Cell Lung Cancer After Surgery Xianhua Xu, MD, Ping-Li Sun,

Malcolm O. Perry, MD, Richard Kempczinski, MD

Ugo Pastorino, MD, Marc Buyse, ScD, Godehard Friedel, MD, Robert J

Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,

Interstitial tumor-associated macrophages combined with tumor-derived colony- stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non–small.

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer J. Buhr,

Lorenzo Spaggiari, MD, PhD, Ugo Pastorino, MD

Editorial: The core of leadership

Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non- small Cell Lung Cancer Tomofumi Yohena, MD, Ichiro Yoshino, MD,

Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma Po-Kuei Hsu, MD,

The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer Yukito Ichinose, MDa, Tokujiro.

Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small.

Reduced membranous β-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus Po-Kuei.

Expression of vascular endothelial growth factor in thoracic sarcomas

Clinical Significance of Epidermal Growth Factor Receptors in Non-small Cell Lung Cancer and a Prognostic Role for HER2 Gene Copy Number in Female Patients

Subclavian artery involvement by apical chest tumors: A specific indication for the transmanubrial approach Lorenzo Spaggiari, MD, PhD, Ugo Pastorino,

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

Angiogenic Markers Show High Prognostic Impact on Survival in Marginally Operable Non-small Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy

Prognostic assessment of 1310 patients with non–small-cell lung cancer who underwent complete resection from 1980 to 1993 Kunihiko Inoue, MDa, Masami.

Prognostic Impact of Node Involvement Pattern in Pulmonary pN1 Squamous Cell Carcinoma Patients Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Genichiro.

ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.

Stephen R. Broderick, MD, MPHS

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl Lewis X, and sialyl Lewis a in lung cancer Jun-ichi Ogawa, MD,

Differential diagnosis of thymic carcinoma and lung carcinoma with the use of antibodies to cytokeratins Ichiro Fukai, MDa, Akira Masaoka, MD, PhDa,

Time trends and survival after operations for primary lung cancer from 1976 through 1990 Hiromi Wada, MD, Fumihiro Tanaka, MD, Kazuhiro Yanagihara, MD,

Yuji Tachimori, MD, Hoichi Kato, MD, Hiroshi Watanabe, MD

Reviewer Acknowledgment

Significance of Smoking as a Postoperative Prognostic Factor in Patients with Non- small Cell Lung Cancer Takeshi Hanagiri, MD, PhD, Kenji Sugio, MD,

Lymph Node Metastasis In Small Peripheral Adenocarcinoma Of The Lung

Carcinoma of the esophagus: Prognostic significance of histologic type

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Superior sulcus lung tumors: Impact of local control on survival

Discussion The Journal of Thoracic and Cardiovascular Surgery

Neal S Goldstein, MD The Annals of Thoracic Surgery

Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma Kuang-Tai Kuo, MD, Kuan-Chih Chow, PhD, Yu-Chung.

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence Akira Ohgami, MD, Tohru Tsuda, MD, Toshihiro Osaki,

Aritoshi Hattori, MD, Kenji Suzuki, MD

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Who should decide margin length in pulmonary excision of lung cancer?

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung.

Time Trends of Surgical Outcome in Patients with Non-small Cell Lung Cancer Takeshi Hanagiri, MD, PhD, Tetsuro Baba, MD, PhD, Tetsuya So, MD, PhD, Manabu.

Nael Martini, MDa, Valerie W. Rusch, MDa, Manjit S. Bains, MDa, Mark G

Presentation transcript:

Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma Hideyuki Imoto, MD, Toshihiro Osaki, MD, Satoshi Taga, MD, Akira Ohgami, MD, Yuji Ichiyoshi, MD, Kosei Yasumoto, MD The Journal of Thoracic and Cardiovascular Surgery Volume 115, Issue 5, Pages 1007-1014 (May 1998) DOI: 10.1016/S0022-5223(98)70398-8 Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Immunohistochemical staining of VEGF. A, Positive VEGF immunostaining of squamous cell carcinoma. VEGF was mainly localized in the cytoplasm of the tumor cells (original magnification ×400). B, Negative VEGF immunostaining of squamous cell carcinoma (original magnification ×400). The Journal of Thoracic and Cardiovascular Surgery 1998 115, 1007-1014DOI: (10.1016/S0022-5223(98)70398-8) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 Survival curves of the 91 patients according to the VEGF expression. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 1007-1014DOI: (10.1016/S0022-5223(98)70398-8) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 Survival curves of the 34 patients with squamous cell carcinoma according to the VEGF expression. The Journal of Thoracic and Cardiovascular Surgery 1998 115, 1007-1014DOI: (10.1016/S0022-5223(98)70398-8) Copyright © 1998 Mosby, Inc. Terms and Conditions